Metabolon Receives NIH Grant to Develop Advanced Monitoring and Predictive Tools for Type 1 Diabetes Progression

Metabolon Receives NIH Grant to Develop Advanced Monitoring and Predictive Tools for Type 1 Diabetes Progression (Di martedì 25 giugno 2024) MORRISVILLE, N.C., June 25, 2024 /PRNewswire/

 Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic Development, and precision medicine applications, is proud to announce the receipt of a prestigious Grant from the National Institutes of Health (NIH) to Develop an innovative product aimed at better Monitoring and predicting the conversion of preclinical asymptomatic Type 1 Diabetes (T1D) to clinical symptomatic, insulin-dependent Type 1 Diabetes. Over 3 million people in the United States live with T1D. Today, the biomarkers that predict the Progression of preclinical T1D to clinical T1D lack specificity and granularity. Despite advances in medical research, no single FDA-approved test currently can monitor T1D Progression beyond simple disease staging.Leggi tutta la notizia su liberoquotidiano